210 results on '"Petruccioli, Elisa"'
Search Results
2. Host biomarker-based quantitative rapid tests for detection and treatment monitoring of tuberculosis and COVID-19
3. Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study
4. Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2
5. Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients
6. In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy
7. Characterization of the Monkeypox Virus [MPX]-Specific Immune Response in MPX-Cured Individuals Using Whole Blood to Monitor Memory Response.
8. Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection
9. Latent tuberculosis infection screening in persons newly-diagnosed with HIV infection in Italy: A multicentre study promoted by the Italian Society of Infectious and Tropical Diseases
10. Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection
11. QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis
12. Characterization of QuantiFERON-TB-Plus results in latent tuberculosis infected patients with or without immune-mediated inflammatory diseases
13. Alternative biomarkers of tuberculosis infection in patients with immune-mediated inflammatory diseases
14. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection
15. Impact of antiretroviral and tuberculosis therapies on CD4+ and CD8+ HIV/M. tuberculosis-specific T-cell in co-infected subjects
16. Evaluation of Cross-Immunity to the Mpox Virus Due to Historic Smallpox Vaccination
17. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients
18. First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus
19. Host biomarker-based quantitative rapid tests for detection and treatment monitoring of tuberculosis and COVID-19
20. Assessment of CD27 expression as a tool for active and latent tuberculosis diagnosis
21. Granzyme A as a potential biomarker of Mycobacterium tuberculosis infection and disease
22. IL-4 specific-response in whole blood associates with human Cystic Echinococcosis and cyst activity
23. Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients
24. High urine IP-10 levels associate with chronic HCV infection
25. Effect of therapy on Quantiferon-Plus response in patients with active and latent tuberculosis infection
26. Clinical isolates of the modern Mycobacterium tuberculosis lineage 4 evade host defense in human macrophages through eluding IL-1β-induced autophagy
27. Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy
28. Autophagy in Mycobacterium tuberculosis infection: A passepartout to flush the intruder out?
29. IFNγ/TNFα specific-cells and effector memory phenotype associate with active tuberculosis
30. Specific T Cells Restore the Autophagic Flux Inhibited by Mycobacterium tuberculosis in Human Primary Macrophages
31. IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country
32. Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis
33. Mycobacterium tuberculosis Immune Response in Patients With Immune-Mediated Inflammatory Disease
34. In Vitro Models for Studying Entry, Tissue Tropism, and Therapeutic Approaches of Highly Pathogenic Coronaviruses
35. Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis
36. Bystander inhibition of dendritic cell differentiation by Mycobacterium tuberculosis-induced IL-10
37. Epidemic and pandemic viral infections: impact on tuberculosis and the lung
38. Mycobacterium tuberculosis induces a bystander effect on DC differentiation through the release of IL-10
39. Translational tuberculosis research: immune profile as biomarker of tuberculosis infection
40. Optimization of the autophagy measurement in a human cell line and primary cells by flow cytometry
41. Humoral- and T-Cell–Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies
42. Anti-inflammatory and anti-tubercular properties screening of natural products from Plectranthus species
43. Modulation of whole-blood IGRA response in patients with latent TB infection during treatment
44. Evaluation of IP-10 in IGRA for LTBI diagnosis
45. Accuracy of whole blood IGRA in TB subjects with rheumatic disease
46. Antitubercular and anti-inflammatory properties screening of natural products from Plectranthus species
47. Impact of antiretroviral and tuberculosis therapies on CD4 + and CD8 + HIV/M. tuberculosis-specific T-cell in co-infected subjects
48. Mycobacterium tuberculosis-specific CD8(+) T cells are functionally and phenotypically different between latent infection and active disease
49. Impact of pe_pgrs33 gene polymorphisms on mycobacterium tuberculosis infection and pathogenesis
50. Impact of pe_pgrs33 Gene Polymorphisms on Mycobacterium tuberculosis Infection and Pathogenesis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.